Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
Clinical trial NCT04523727 · SUSPENDED
Trial details
- NCT number
- NCT04523727
- Sponsor
- Keryx Biopharmaceuticals
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-16
- Primary completion
- 2026-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.